# Efficacy of Optison Echo Contrast to Detect Thrombus in Left Atrial Appendage

Study · id `cardio:ct-nct01721447` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01721447](<https://clinicaltrials.gov/study/NCT01721447>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01721447

Browse, organ or system: Heart; Brain  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

## Technical summary

Registry record NCT01721447. Allocation not applicable; no masking; primary purpose diagnostic. Start 2013-06 (registry gives no type); primary completion 2018-05 (actual). Results posted on 2019-06-04.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase: Phase 4
- Enrolled: 100 participants (enrolled count; ClinicalTrials.gov record NCT01721447, source copy `cardio:ctgov-nct01721447-2019-08-20`, retrieved 2026-10-26)
- Start date: 2013-06 (registry gives no type) (ClinicalTrials.gov record NCT01721447, source copy `cardio:ctgov-nct01721447-2019-08-20`, retrieved 2026-10-26)
- Primary completion: 2018-05 (actual) (ClinicalTrials.gov record NCT01721447, source copy `cardio:ctgov-nct01721447-2019-08-20`, retrieved 2026-10-26)
- Completion: 2018-05 (actual) (ClinicalTrials.gov record NCT01721447, source copy `cardio:ctgov-nct01721447-2019-08-20`, retrieved 2026-10-26)
- Results first posted: 2019-06-04 (ClinicalTrials.gov record NCT01721447, source copy `cardio:ctgov-nct01721447-2019-08-20`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT01721447, source copy `cardio:ctgov-nct01721447-2019-08-20`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01721447-2019-08-20`, retrieved 2026-10-26)

## The registry's words

- Brief title: Efficacy of Optison Echo Contrast to Detect Thrombus in Left Atrial Appendage
- Acronym: DOLOP
- Condition: Atrial Fibrillation
- Intervention (Drug): Optison echocardiography contrast agent
- Lead sponsor: University of Utah
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: University of Utah (`cardio:org-university-of-utah`)

## Provenance

Content hash: 988f7e995f84a3153708bd6b868a082105734faa30df9910a3c7cdb36f09ba61
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
